UViiVE provides an AI‑driven, fully automated platform that designs, synthesizes, and tests peptide bioactives for skin care. Its fleet of AI agents generates and ranks candidate sequences, which are then produced and assayed by robotic liquid‑handling systems in a continuous 24/7 design‑test‑rank loop, delivering validated peptide therapeutics to dermatology and cosmetics companies faster and at scale.
Funding
Funding not disclosed
Founders
Product
Problem
Developing effective skin‑care bioactives requires extensive peptide design, synthesis, and testing cycles that are labor‑intensive, time‑consuming, and dependent on specialized wet‑lab personnel, limiting speed to market and scalability.
Solution
UViiVE offers an AI‑native full‑stack platform that autonomously designs precision peptides targeting the underlying causes of skin conditions and validates them through continuous robotic execution. Specialized AI agents—Uvy for experiment planning and literature mining, Atlas for structural modeling, and Buster for protein folding—coordinate a shared memory system that generates candidate sequences, ranks them, and hands them off to a fleet of liquid‑handling robots. The robots perform cell‑free synthesis and functional assays, measuring binding affinity and activity without human intervention. The design‑test‑rank loop runs 24/7, iteratively improving peptide candidates as data accumulate. This closed‑loop automation accelerates the path from in‑silico concept to validated bioactive, enabling rapid commercialization of peptide therapeutics for skin health.
Target Audience
Primary customers are dermatology‑focused pharmaceutical and cosmetics companies, as well as biotech firms developing peptide‑based skin therapeutics that require rapid, high‑throughput candidate validation.
Features
- AI agent fleet (Uvy, Atlas, Buster) that mines literature, runs structural inference, and performs protein folding to generate and rank peptide candidates
- Integrated robotic layer for high‑throughput liquid handling, cell‑free peptide synthesis, and functional assays (e.g., Kd measurement)
- Continuous 24/7 design‑test‑rank loop that self‑optimizes with each experimental cycle
- Shared memory architecture allowing seamless handoff between AI planning and physical execution
- End‑to‑end workflow from de novo peptide design to experimental validation without human operators
- Focus on topical skin‑care bioactives addressing UV‑triggered sensitivity, reactive inflammation, barrier impairment, and post‑procedure recovery